Diagnostic Antibody Discovery
Specificity that scales
Customizable antibody discovery workflows engineered for high-affinity binding, sensitivity, and exquisite specificity to address demanding diagnostic challenges.
Every diagnostic matters. Every result counts.
In diagnostics, accuracy matters. MindWalk unites advanced lab rigor with scalable development to deliver antibodies with specificity, sensitivity, and reproducibility. With a validated discovery platform and rapid screening formats, our diagnostic antibody discovery workflow supports researchers as projects move from discovery toward downstream development.
500+ antibody diagnostic programs
Your extended team
Customized strategies for diagnostic antibody discovery. Decades of client retention built on scientific rigor and trusted collaboration.
>98% discovery success rate
with leading B cell technology*
* “Success” refers to meeting predefined discovery criteria, not clinical or therapeutic outcomes. Results may vary.
Diagnostic antibody discovery performance
From standard to complex programs, our antibodies are characterized by sensitivity, specificity, and cross-platform accuracy.
Specificity
Target the most difficult-to-distinguish markers
Sensitivity
Designed for hard-to-find, low-abundance targets with precision
Reproducibility
Consistent performance across assays with low batch-to-batch variation
Stability
Durability and performance that withstand demanding workflows
Comprehensive expertise for advanced diagnostic solutions
Advanced diagnostic lab research:
Our antibody discovery platforms span the full journey—from target identification through protein production, with antibodies characterized by precise specificity, low background, and high sensitivity.
Integrated LensAI™ support:
Customized intelligence built for you, ready when you need it, revealing insights that help shape more refined clones.
Flexible protein production:
High-throughput, consistent expression that scales as programs progress.
Where our research makes a broad impact
Oncology + Infectious Disease + Neurodegeneration + Metabolic Disease + Rare Disease + Inflammation + Market Kits
Diagnostics discovery across complex targets
End-to-end antibody discovery + development
Wide-range of flexible applications
Target
- Target Analysis: Experience-based Antigen Design
- Tool Generation: Custom Antigen Production, Assay Development
Discovery
- Immunization: Standard, Rapid, Custom
- Hit Generation & Candidate Selection: B cell Discovery, Hybridoma Discovery
Lead
- Lead Characterization: Target Interaction Analysis
- LensAI HYFT Prime™: Binding Affinity Optimization, Target Specificity and Selectivity
- Target- and Application-specific Screening
- Protein Production: Recombinant Protein Expression in CHO, HEK293, E.coli
Stable Production Cell Line
Secure Cryostorage
Functional Selection
- Epitope Mapping
- Affinity
- Specificity
- Competing/Non-competing
- Pairing Identification
- Application Relevant Screening
Species Diversity
+ Rabbit
+ Rodent
Advanced Technology
+ B cell Select® Antibody Discovery
+ Hybridoma Antibody Discovery
Format Options
- Full-length IgG
- Custom Formats
Explore wet lab antibody discovery technologies in depth. Learn how individual antibody discovery technologies, function-first screening, end-to-end discovery workflows, and integrated AI analysis help discovery teams support antibody programs. Learn more
Used by teams across 19 of the top 20 global pharma companies, next-generation biotechs, and leading research institutions
Stronger starts.
#1 ranking lab1
1. ROOTS 2022: Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035; p.118
Protein production
Leading diagnostics developers rely on our high-purity, reproducible proteins in long-standing relationships.
Talk 1:1 with the team
Connect with a team who understands Diagnostics from discovery through development
Four ways to access MindWalk
We build it
Customizable offerings in biologics discovery—from target analysis to optimized leads.
You build it
Access to state-of-the-art LensAI SaaS Platform.
The Vault
Smarter starts: a portfolio of partner-ready assets.
Partnership
We are proud to partner with the best in pharma, biotech and academia organizations. Join us in creating future of human health.
FAQs
-
What should I look for in a diagnostic antibody discovery partner?
For diagnostic antibody discovery, teams should evaluate whether a partner can design the workflow around the assay outcome, not just antibody generation. Important criteria include specificity, sensitivity, low background, reproducibility, antigen strategy, antibody pairing, production capabilities, and experience with complex or difficult-to-detect targets.
-
What makes diagnostic antibody discovery different from other antibody discovery?
Diagnostic antibodies have to perform in the assay conditions where detection happens. That means candidates must be assessed for binding behavior, specificity, background, reproducibility, epitope compatibility, pairing potential, and performance under application-relevant conditions.
-
Can MindWalk develop antibodies for challenging diagnostic targets?
Yes. For rare, complex, low MV, low-abundance, or difficult-to-detect targets, MindWalk can customize discovery workflows around the target biology, assay format, antigen strategy, screening requirements, and downstream validation needs.
-
How are matched antibody pairs identified for diagnostic assay development?
Matched antibody pair development requires more than finding two antibodies that bind the same target. Candidate pairs must recognize compatible epitopes, avoid unwanted competition, limit cross-reactivity, and perform together in the intended assay system. MindWalk can evaluate antibody pairs through epitope analysis, affinity and specificity testing, competing and non-competing assessment, and application-relevant screening.
-
How does MindWalk help improve diagnostic assay performance?
MindWalk helps improve diagnostic assay performance through a Function-First approach that evaluates antibody candidates in the context of their intended diagnostic use. Candidates can be assessed for specificity, reproducibility, pairing potential, cross-reactivity, background, and compatibility with the intended assay format.
Early antibody material can also be provided for client testing within the intended kit or platform. This enables assay-specific feedback earlier in the research process and helps inform candidate selection and further optimization.
-
Does MindWalk support diagnostic antibody validation and production?
Yes. MindWalk can support diagnostic antibody programs from discovery through validation and production, helping teams move from target requirements to usable diagnostic reagents. Production support can include recombinant protein expression and antibody production for assay development, lead characterization, and downstream diagnostic workflows.